CYP cynata therapeutics limited

9.68%

17.0¢

Ann: Quarterly Activity Report & Appendix 4C, page-57

First 57 Last

Share
Profile

Follow
Pledge

8,722 Posts.

1455

01/11/22

18:59

Post #: 64530414
Share

Originally posted by bedger: ↑

Excellent use of time guys. Though CYP making a 5-year low of $0.30, the CYP trolls fell they will have been rewarded. There is demand by the way. I will happily buy more under $0.30 if some of you trolls are game to short sell CYP?

The formal SCUlpTOR trial news is disappointing, but hardly surprising and out of the control of CYP, just as the NIH trial of C-19 ARDS was for MSB (and royally messed up to the detriment of wider society, not just MSB shareholders). You boys might as well be saying "your plight is as crap as ours was". The recent performance of CYP and MSB in trials has been hugely disappointing in both. Its just degrees of. It is no wonder both are pretty much on 5 year lows. One day you guys will wake up to shared synergies despite the different approaches.

Contrary to CYP's release, there HAVE been human clinical studies that suggest MSC's DO have "the ability to produce a tissue
regenerative response, leading to a potential breakthrough in the US$11.6bn1 global osteoarthritis market". Which bodes well for CYP and the sector generally.

Expand

Zero interest. Including shorters.

https://www.shortman.com.au/stock?q=cyp

For shorters to be successful they have to have access to market supply and demand to be able to exit. There is none.

All shareholders are stuck toight.

Hail Mary, full of grace........etc. etc.

Last edited by Pledge: 01/11/22

CYP Price at posting: 30.0¢ Sentiment: None Disclosure: Not Held
2 Upvote

2 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

First 57 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change 0.015(9.68%)		Mkt cap ! $38.41M

Open	High	Low	Value	Volume
15.5¢	17.0¢	15.5¢	$47.10K	289.1K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	23813	3

View Market Depth

No.	Vol.	Price($)
1	50000	0.165
4	47240	0.155
4	161673	0.150
1	5000	0.145
2	45000	0.140

Price($)	Vol.	No.
0.170	18813	2
0.175	55250	1
0.180	62619	3
0.185	35990	1
0.195	19300	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

CYP (ASX) Chart

Ann: Quarterly Activity Report & Appendix 4C, page-57

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activity Report & Appendix 4C, page-57

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News